Cell Therapy Clinical Trial Services Market Share Report, 2032

Cell Therapy Clinical Trial Services Market – By Service (Clinical Trial Design & Planning, Regulatory Affairs & Compliance), Phase (I, II, III, IV), Indication (Oncology, Cardiovascular), End-use (Pharma & Biotech, CRO) – Global Forecast (2024 – 2032)

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600&nbsp;synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Rising incidence of chronic and genetic diseases

3.2.1.2&nbsp;&nbsp;&nbsp; Technological advancement in cell therapy

3.2.1.3&nbsp;&nbsp;&nbsp; Increasing investment in research &amp; development activities

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp; Regulatory challenges

3.2.2.2&nbsp;&nbsp;&nbsp; Complexity of cell therapy development

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.6&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Strategic dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Service, 2021 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Clinical trial design &amp; planning

5.3&nbsp;&nbsp;&nbsp; Supply &amp; logistics services

5.4&nbsp;&nbsp;&nbsp; Regulatory affairs &amp; compliance

5.5&nbsp;&nbsp;&nbsp; Data management &amp; biostatistics

5.6&nbsp;&nbsp;&nbsp; Site management &amp; monitoring

5.7&nbsp;&nbsp;&nbsp; Other services

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Phase, 2021 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Phase I

6.3&nbsp;&nbsp;&nbsp; Phase II

6.4&nbsp;&nbsp;&nbsp; Phase III

6.5&nbsp;&nbsp;&nbsp; Phase IV

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Indication, 2021 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Oncology

7.3&nbsp;&nbsp;&nbsp; Hematology

7.4&nbsp;&nbsp;&nbsp; Neurology

7.5&nbsp;&nbsp;&nbsp; Cardiovascular diseases

7.6&nbsp;&nbsp;&nbsp; Musculoskeletal disorders

7.7&nbsp;&nbsp;&nbsp; Other indications

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End-use, 2021 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Pharmaceutical &amp; biotechnology companies

8.3&nbsp;&nbsp;&nbsp; Contract research organizations

8.4&nbsp;&nbsp;&nbsp; Academic &amp; research institutes

8.5&nbsp;&nbsp;&nbsp; Other end-users

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2032 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; North America

9.2.1&nbsp;&nbsp;&nbsp; U.S.

9.2.2&nbsp;&nbsp;&nbsp; Canada

9.3&nbsp;&nbsp;&nbsp; Europe

9.3.1&nbsp;&nbsp;&nbsp; Germany

9.3.2&nbsp;&nbsp;&nbsp; UK

9.3.3&nbsp;&nbsp;&nbsp; France

9.3.4&nbsp;&nbsp;&nbsp; Spain

9.3.5&nbsp;&nbsp;&nbsp; Italy

9.3.6&nbsp;&nbsp;&nbsp; Netherlands

9.3.7&nbsp;&nbsp;&nbsp; Rest of Europe

9.4&nbsp;&nbsp;&nbsp; Asia Pacific

9.4.1&nbsp;&nbsp;&nbsp; Japan

9.4.2&nbsp;&nbsp;&nbsp; China

9.4.3&nbsp;&nbsp;&nbsp; India

9.4.4&nbsp;&nbsp;&nbsp; Australia

9.4.5&nbsp;&nbsp;&nbsp; South Korea

9.4.6&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

9.5&nbsp;&nbsp;&nbsp; Latin America

9.5.1&nbsp;&nbsp;&nbsp; Brazil

9.5.2&nbsp;&nbsp;&nbsp; Mexico

9.5.3&nbsp;&nbsp;&nbsp; Rest of Latin America

9.6&nbsp;&nbsp;&nbsp; Middle East and Africa

9.6.1&nbsp;&nbsp;&nbsp; South Africa

9.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

9.6.3&nbsp;&nbsp;&nbsp; UAE

9.6.4&nbsp;&nbsp;&nbsp; Rest of Middle East and Africa

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles

10.1&nbsp;&nbsp;&nbsp; ICON PLC

10.2&nbsp;&nbsp;&nbsp; IQVIA

10.3&nbsp;&nbsp;&nbsp; Medpace, Inc.

10.4&nbsp;&nbsp;&nbsp; Laboratory Corporation of America Holdings

10.5&nbsp;&nbsp;&nbsp; Parexel International

10.6&nbsp;&nbsp;&nbsp; Worldwide Clinical Trials

10.7&nbsp;&nbsp;&nbsp; Charles River Laboratories International, Inc.

10.8&nbsp;&nbsp;&nbsp; Syneos Health

10.9&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific Inc.

10.10&nbsp;&nbsp;&nbsp; Novotech

10.11&nbsp;&nbsp;&nbsp; Catalent Pharma

10.12&nbsp;&nbsp;&nbsp; Precision Medicine Group, LLC 
&nbsp;

Cell Therapy Clinical Trial Services Market

Get a free sample of this report